LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 6 of 15: End-point mean cell counts and mean normalized growth rate inhibition values for biological replicate 3. - Dataset (ID:20314)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 82.40 | 56.33 | 6569 | 7810 | 0.8464 | 0.8700 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 84.10 | 56.33 | 6594 | 7655 | 0.8636 | 0.8666 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 85.80 | 56.33 | 6659 | 7583 | 0.8803 | 0.8736 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 87.50 | 56.33 | 6640 | 7334 | 0.9067 | 0.8759 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 89.20 | 56.33 | 6728 | 7229 | 0.9314 | 0.8863 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 90.90 | 56.33 | 6818 | 7174 | 0.9515 | 0.8898 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 92.60 | 56.33 | 6788 | 7065 | 0.9621 | 0.8843 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 94.30 | 56.33 | 6795 | 6924 | 0.9818 | 0.8799 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 95.70 | 27.76 | 7130 | 6712 | 1.0623 | 0.8980 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 2.30 | 56.33 | 285 | 255 | 1.1304 | 0.5223 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 4.00 | 56.33 | 327 | 303 | 1.0855 | 0.4781 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 5.70 | 56.33 | 370 | 342 | 1.0850 | 0.4567 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 7.40 | 56.33 | 411 | 385 | 1.0712 | 0.4384 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 9.10 | 56.33 | 453 | 424 | 1.0716 | 0.4307 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 10.80 | 56.33 | 490 | 465 | 1.0578 | 0.5294 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 12.50 | 56.33 | 568 | 510 | 1.1143 | 0.7037 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 14.20 | 56.33 | 704 | 634 | 1.1125 | 0.8466 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 15.90 | 56.33 | 801 | 726 | 1.1076 | 0.8829 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 17.60 | 56.33 | 991 | 868 | 1.1462 | 0.9183 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 19.30 | 56.33 | 1153 | 1090 | 1.0926 | 0.8972 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 21.00 | 56.33 | 1296 | 1286 | 1.0432 | 0.8917 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 22.80 | 56.33 | 1435 | 1460 | 1.0079 | 0.8799 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 24.50 | 56.33 | 1543 | 1615 | 0.9760 | 0.8777 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 26.20 | 56.33 | 1669 | 1764 | 0.9657 | 0.8815 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 27.90 | 56.33 | 1783 | 1907 | 0.9568 | 0.8783 |